Phase I/II evaluation of effervescent and enteric coated oral pamidronate for bone metastases.
Coleman
R E
RE
Dirix
L Y
LY
Dodwell
D
D
Tubiana-Hulin
M
M
Body
J J
JJ
Becher
R
R
White
G K
GK
Rubens
R D
RD
Van Oosterom
A
A
Howell
A
A
D000284:Administration, Oral; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary*; D004164:Diphosphonates / Q000008:administration & dosage; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008875:Middle Aged; D000077268:Pamidronate; D013608:Tablets, Enteric-Coated
D004164:Diphosphonates; D013608:Tablets, Enteric-Coated; D000077268:Pamidronate